The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 04, 2018
Filed:
Apr. 16, 2010
Applicants:
Carsten Tschöpe, Berlin, DE;
H. P. Schultheiss, Berlin, DE;
Felicitas Escher, Berlin, DE;
Hans-dieter Volk, Berlin, DE;
Petra Reinke, Berlin, DE;
Inventors:
Carsten Tschöpe, Berlin, DE;
H. P. Schultheiss, Berlin, DE;
Felicitas Escher, Berlin, DE;
Hans-Dieter Volk, Berlin, DE;
Petra Reinke, Berlin, DE;
Assignee:
Charité—Universitätsmedizin Berlin, Berlin, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/36 (2006.01); A61K 39/395 (2006.01); A61K 38/00 (2006.01); C07K 16/28 (2006.01); A61K 49/00 (2006.01); G01N 33/569 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 39/39541 (2013.01); A61K 47/6849 (2017.08); A61K 49/0002 (2013.01); A61K 49/0004 (2013.01); C07K 16/2896 (2013.01); G01N 33/56972 (2013.01); G01N 2800/325 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention is related to a B-lymphocyte targeting agent for use in a method for the treatment or diagnosis of cardiac insufficiency. Furthermore, it is related to a composition comprising such B-lymphocyte targeting agent and methods for determining whether a patient suffering from cardiac insufficiency is amenable to the use of the B-lymphocyte targeting agent for its treatment.